Sinovac Biotech Ltd. (NYSE: SVA) announced that its Board has authorized a program to repurchase Sinovac common shares. The Board ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE